Seth Porter
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Biochemistry top 10%
- Blood transfusion and management
Papers in
-
- Blood transfusion and management 2
- Oncology 2
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Thomas B. Neff (3 shared papers)Mary Beth Scholand (2 shared papers)Jonathan Gerald Goldin (2 shared papers)Kevin R. Flaherty (2 shared papers)Ganesh Raghu (2 shared papers)Stanley C. Froehner (1 shared paper)Elias Kouchakji (2 shared papers)Eduard Gorina (1 shared paper)
- Journals
- Transfusion (2 papers)European Respiratory Journal (1 paper)ESMO Open (1 paper)British Journal of Pharmacology (1 paper)The Lancet Respiratory Medicine (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Seth Porter
9 papers receiving 758 citations
Seth Porter's Hit Papers
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 264
- Biochemistry 53
- Immunology 85
- Oncology 60
- Cellular and Molecular Neuroscience 37
Countries citing papers authored by Seth Porter
This map shows the geographic impact of Seth Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Porter more than expected).
Fields of papers citing papers by Seth Porter
This network shows the impact of papers produced by Seth Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Porter. The network helps show where Seth Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2019 | 246 |
| 2 | 2016 | 158 | |
| 3 | 2001 | 144 | |
| 4 | 1997 | 81 | |
| 5 | 2020 | 59 | |
| 6 | 1985 | 44 | |
| 7 | 2005 | 40 | |
| 8 | 2006 | 21 | |
| 9 | FG-3019, A Human Monoclonal Antibody to Connective Tissue Growth Factor, Combined with Chemotherapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | 2016 | 8 |
About Seth Porter
Seth Porter is a scholar working on Biochemistry, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 801 indexed citations. Recurring topics across this work include Blood transfusion and management (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Lipid Membrane Structure and Behavior (1 paper), Receptor Mechanisms and Signaling (1 paper), Blood Pressure and Hypertension Studies (1 paper), Nicotinic Acetylcholine Receptors Study (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (264 citations), Biochemistry (53 citations), Immunology (85 citations), Oncology (60 citations) and Cellular and Molecular Neuroscience (37 citations). Seth Porter has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Thomas B. Neff, Mary Beth Scholand, Jonathan Gerald Goldin, Kevin R. Flaherty, Ganesh Raghu, Stanley C. Froehner, Elias Kouchakji, Eduard Gorina, Evans R. Fernández Pérez and David J. Lederer. Their work appears in journals such as Transfusion, European Respiratory Journal, ESMO Open, British Journal of Pharmacology and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.